Einrichtungen, die zum Universitätsklinikum Erlangen gehören

Comparison and Improvement of CyberGlove III calibration methods (2024) Heinrich S, Michaelis J, Reiher I, Coppers B, Lohmayer M, Fleischmann ME, Kleyer A, et al. Journal article, Original article Gain-of-function and loss-of-function variants in GRIA3 lead to distinct neurodevelopmental phenotypes. (2024) Rinaldi B, Bayat A, Zachariassen LG, Sun JH, Ge YH, Zhao D, Bonde K, et al. Journal article Real-World Effectiveness of Vedolizumab vs Anti-TNF in Biologic-naïve Crohn's Disease Patients: A 2-year Propensity-score-adjusted Analysis from the VEDOIBD-Study. (2024) Bokemeyer B, Plachta-Danielzik S, di Giuseppe R, Efken P, Mohl W, Hoffstadt M, Krause T, et al. Journal article COVID-19 vaccine safety during pregnancy and breastfeeding in women with autoimmune diseases: results from the COVAD study. (2024) Andreoli L, Lini D, Schreiber K, Parodis I, Sen P, Ravichandran N, Day J, et al. Journal article Tixagevimab/cilgavimab for the prevention of COVID-19 in vaccine-refractory patients with autoimmune diseases: a prospective cohort study. (2024) Minopoulou I, Tascilar K, Corte G, Mutlu MY, Schmidt K, Bohr D, Hartmann F, et al. Journal article Aerosol Dispersion During Different Phonatory Tasks in Amateur Singers. (2024) Hermann LA, Tur B, Köberlein MC, Gantner S, Westphalen C, Benthaus T, Döllinger M, et al. Journal article In-hospital Outcomes of Rotational Atherectomy in ST-Elevation Myocardial Infarction: Results From the Multicentre ROTA-STEMI Network (2024) Hemetsberger R, Mankerious N, Muntané-Carol G, Temporal J, Sulimov D, Gaede L, Woitek F, et al. Journal article Artificial intelligence in kidney transplant pathology Künstliche Intelligenz in der Nierentransplantationspathologie (2024) Bülow RD, Lan YC, Amann KU, Boor P Journal article Paradoxical effect of anti-inflammatory drugs on IL-6 mRNA expression in patients with PTSD during treatment (2024) Rhein C, Apelt I, Werner F, Schäflein E, Adler W, Reichel M, Schug C, et al. Journal article Combined inhibition of IL-1, IL-33 and IL-36 signalling by targeting IL1RAP ameliorates skin and lung fibrosis in preclinical models of systemic sclerosis (2024) Grönberg C, Rattik S, Tran-Manh C, Zhou X, Rius Rigau A, Li YN, Györfi AH, et al. Journal article